Abstract:BACKGROUND In clinical practice, the diagnosis is sometimes difficult with contrast-enhanced ultrasound (CEUS) when the case has an atypical perfusion pattern. Color parametric imaging (CPI) is an analysis software for CEUS with better detection of temporal differences in CEUS imaging using arbitrary colors. It measures the differences in arrival time of the contrast agent in lesions so that the perfusion features of atypical hemangioma and colorectal cancer (CRC) liver metastasis can be distinguished. AIM To evaluate the role of a novel type of CPI of CEUS in the differential diagnosis of atypical hemangioma from liver metastases in patients with a history of CRC. METHODS From January 2016 to July 2018, 42 patients including 20 cases of atypical hemangioma and 22 cases of liver metastases from CRC were enrolled. These patients had a mean age of 60.5 +/- 9.3 years (range: 39-75 years). All patients received ultrasound, CEUS and CPI examinations. Resident and staff radiologists independently and retrospectively reviewed CEUS and CPI images. Two sets of criteria were assigned: (1) Routine CEUS alone; and (2) CEUS and CPI. The diagnostic sensitivity, specificity, accuracy and receiver operating characteristic (ROC) curve of resident and staff radiologists were analyzed. RESULTS The following CPI features were significantly different between liver hemangioma and liver metastases analyzed by staff and resident radiologists: Peripheral nodular enhancement (65%-70.0% vs 4.5%-13.6%, P < 0.001, P = 0.001), mosaic/chaotic enhancement (5%-10% vs 68.2%-63.6%, P < 0.001, P < 0.001) and feeding artery (20% vs 59.1%-54.5%, P = 0.010, P = 0.021). CPI imaging offered significant improvements in detection rates compared with routine CEUS in both resident and staff groups. By resident radiologists, the specificity and accuracy of CEUS+CPI were significantly increased compared with that of CEUS (77.3% vs 45.5%, P = 0.030; 78.6% vs 50.0%, P = 0.006). In addition, the area under the curve (AUC) of CEUS+CPI was significantly higher than that of CEUS (0.803 vs 0.757, P = 0.036). By staff radiologists, accuracy was improved in CEUS+CPI (81.0% vs 54.8%, P = 0.010), whereas no significant differences in specificity and sensitivity were found (P = 0.144, P = 0.112). The AUC of CEUS+CPI was significantly higher than that of CEUS (0.890 vs 0.825, P = 0.013) by staff radiologists. CONCLUSION Compared with routine CEUS, CPI could provide specific information on the hemodynamic features of liver lesions and help to differentiate atypical hemangioma from liver metastases in patients with CRC, even for senior radiologists.

A Novel Technology for Resolution of CEUS Imaging Problems in Patients With High BMI and Fatty Liver

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

0605: Treatment Response Evaluation with 3D Contrast-Enhanced Ultrasound for Liver Cancer after Local Therapies

Novel high-resolution contrast agent ultrasound techniques HiFR CEUS and SR CEUS in combination with shear wave elastography, fat assessment and viscosity of liver parenchymal changes and tumors

Parametric Imaging with Contrast-Enhanced Ultrasound: Usefulness for Characterization of Dynamic Effects of Microvascularization for Hepatocellular Carcinoma and Focal Nodular Hyperplasia.

Three-dimensional Contrast-Enhanced Ultrasound of the Liver: Experience of 92 Cases.

1287: A Comparative Study of Contrast-Enhanced Ultrasound and Contrast-Enhanced MRI in Evaluating the Therapeutic Response of Microwave Thermal Ablation for Liver Malignances

Contrast-enhanced Ultrasound in the Characterization of Hepatocellular Carcinomas Treated by Ablation: Comparison with Contrast-Enhanced Magnetic Resonance Imaging.

Undetermined Focal Liver Lesions on Gray-Scale Ultrasound in Patients with Fatty Liver: Characterization with Contrast-Enhanced Ultrasound

Detection and Characterization of Small Superficially Located Focal Liver Lesions by Contrast-Enhanced Ultrasound with High Frequency Transducers.

Treatment Response Evaluation with Three-Dimensional Contrast-Enhanced Ultrasound for Liver Cancer after Local Therapies

New Ultrasonographic Techniques to Differentiate Hepatic Masses: Contrast-Enhanced Ultrasound and Super-Resolution Ultrasound

Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions.

Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study

0047: Impact of Contrast-Enhanced Ultrasound on Diagnosis of Hepatocellular Carcinoma in Cirrhosis: A Large Series Report

Current aspects of multimodal ultrasound liver diagnostics using contrast-enhanced ultrasonography (CEUS), fat evaluation, fibrosis assessment, and perfusion analysis – An update

Profiling Hepatocellular Carcinoma Aggressiveness with Contrast-Enhanced Ultrasound and Gadoxetate Disodium-Enhanced MRI: an Intra-Individual Comparative Study Based on the Liver Imaging Reporting and Data System.

Differentiation of Atypical Hepatic Hemangioma from Liver Metastases: Diagnostic Performance of a Novel Type of Color Contrast Enhanced Ultrasound.

Clinical impact of contrast-enhanced ultrasound on indeterminate or non-characterizable liver nodules on CT/MRI: sub-analysis from a prospective multicenter trial

Dynamic Contrast Ultrasound Diagnostics (CEUS) of Liver Lesions and Post-treatment Control with A New High-resolution Examination Technique (HiFR) and Perfusion

The Interreader Agreement and Validation of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System.